Home LiteratureArticle Details
PMID: 12049538 Published · ppublish English Comparative Study Journal Article Multicenter Study

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization.

Archives of surgery (Chicago, Ill. : 1960) ·Vol. 137 ·No. 6 ·2002-06-00 ·Pages 675-80; discussion 680-1

Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN

Abstract

Preoperative portal vein embolization (PVE) allows potentially curative hepatic resection without additional morbidity or mortality in patients with hepatobiliary malignancies who are marginal candidates for resection based on small liver remnant size. A retrospective review of a consecutive series of patients in a multi-institutional database who underwent extended hepatectomy. University-based referral centers. Forty-two patients underwent preoperative determination of the future liver remnant (FLR) volume before extended hepatectomy (> or = 5 segments) for hepatobiliary malignancy without chronic underlying liver disease. Patients were stratified by treatment with or without preoperative PVE. Preoperative percutaneous PVE. Clinical characteristics, FLR volume, operative morbidity, and survival. There was no difference between the groups that did and did not undergo PVE for the number of tumors, tumor size, estimated blood loss, duration of the operation, complexity of resection, or surgical margins. The FLR at presentation was significantly smaller in patients who underwent PVE than in patients who did not undergo PVE (18% vs 23%; P<.001). After PVE, FLR volumes increased significantly (P =.003); preoperative FLR volumes were similar in both groups (patients who underwent PVE, 25%; and patients who did not undergo PVE, 23%). There was no perioperative mortality and no statistical difference in the incidence of perioperative complications between those who did and those who did not undergo PVE (5 [28%] of 18 patients vs 5 [21%] of 24 patients). The overall 3-year survival was 65% and the median survival duration was equivalent in the 2 groups (40 vs 52 months for those who did vs those who did not undergo PVE). Portal vein embolization enables safe and potentially curative extended hepatectomy in a subset of patients who would otherwise be marginal candidates for resection based on a small liver remnant size.

MeSH Terms
Adult Aged Bile Duct Neoplasms/surgery Bile Ducts, Intrahepatic Biliary Tract Neoplasms/secondary,surgery Carcinoma, Hepatocellular/surgery Cholangiocarcinoma/surgery Colorectal Neoplasms/pathology Embolization, Therapeutic Female Hepatectomy/methods Hepatic Veins Humans Liver Neoplasms/secondary,surgery Male Middle Aged Retrospective Studies
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Abdalla Eddie K
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Barnett Carlton C
Doherty Dorota
Curley Steven A
Vauthey Jean-Nicolas
Article Info
Journal
Archives of surgery (Chicago, Ill. : 1960)
Abbr.
Arch Surg
ISSN
0004-0010
Published
2002-06-00
Pages
675-80; discussion 680-1
Language
English
Region
United States
NLM ID
9716528
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com